Your session is about to expire
← Back to Search
Cannabidiol for Alcohol Use Disorder
Study Summary
This trial is testing if CBD can help reduce drinking in people with alcohol use disorder. Subjects will get one of 3 treatments for 12 wks.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I use CBD products for health reasons.I am currently taking medication for seizures.I want to cut down or stop drinking alcohol.I am not pregnant, nursing, or I am using reliable birth control.I am taking medication that interacts with Epidiolex.I am 21 years old or older.I drink at least 15 (if male) or 10 (if female) alcoholic drinks weekly.I am taking medication that affects my alcohol consumption.I can go to the study site for visits.You must meet one of the following criteria related to alcohol consumption:I want to cut down or stop drinking alcohol.I drink at least 21 (if male) or 14 (if female) alcoholic drinks weekly.You currently have an Alcohol Use Disorder that is moderate or severe. This means you experience at least four symptoms listed in the DSM-V criteria.
- Group 1: Full-Spectrum Cannabidiol
- Group 2: Placebo
- Group 3: Broad-Spectrum Cannabidiol
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants currently being accepted into this research project?
"Affirmative. Information available on clinicaltrials.gov denotes that patient recruitment for this trial is still active; it was first posted March 31st 2023 and last updated 15th of the same month. The study requires 180 participants from 1 site to complete its research goals."
How extensive is the scope of individuals receiving treatment as part of this trial?
"Affirmative. Clinicaltrials.gov records show that this active clinical trial, which was first put up on March 31st 2023, is still looking for participants to join in. 180 people are needed at a single location."
What are the aims of this research endeavor?
"The primary outcome monitored over 12 weeks of this trial is Change in Alcohol Dependence/Craving. Secondary targets include Change in Sleep Disturbance, as measured by the PROMIS Short Form v1.0 - Sleep Disturbance; Change in Anxiety, as quantified via the Depression Anxiety Stress Scale (DASS); and lastly, Change in Pain Levels which will be gauged using the PROMIS Numeric Rating Scale v1.0 - Pain Intensity."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger